Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Clinic Operations topic
No spam. Unsubscribe anytime.
Director outlines seasonal walk-in clinic, flags HRSA grant timing and pharmacy revenue gains
Summary
Director Wall told the planning committee the clinic is considering a seasonal walk-in clinic to absorb tourist demand, cited improved pharmacy revenue after Medicaid began paying in March, and said HRSA moved grant cycles from three to four years with unclear financial implications.
Get email alerts on the Clinic Operations topic
No spam. Unsubscribe anytime.
Director Wall presented the quarterly directors report and outlined a proposal to open a seasonal walk-in clinic to absorb low-acuity tourist demand and reduce pressure on the clinics emergent-services line.
Wall told the committee March was "a huge month for the pharmacy because Medicaid finally started paying," and said that pharmacy reimbursements materially improved cash flow. At the same time, Wall warned the committee the locum-tenens budget remains a significant expense: "In 2025 that line was $1,200,000; this year, even with budget adjustments, it's still on at $950,000," figures Wall cited as staff estimates.
Wall described the walk-in-clinic model as a short-visit (about 20 minutes) service targeted at minor, non-life-threatening conditions common among seasonal visitors. Operational details discussed included using Charm (a web-based EHR used by regional walk-in clinics), separate contracts and subaccounting for the walk-in enterprise, malpractice insurance and business licenses, and scheduling to match peak cruise-ship arrival windows. Wall said some local providers and seasonal clinicians have expressed interest and that a summer-only model (May——September) would reduce the clinics demand for expensive locum coverage.
On grant timing, Wall said the clinic received notice HRSA is moving FQHC grant cycles from three years to four years without a corresponding increase in the award line, and staff said they have not yet received guidance on the financial implications. "We have no guidance from HRSA at this time," Wall said; committee members asked the director to research the bulletin text and report back to the board.
Committee members pressed for financial projections. Finance-committee members had earlier asked for a summary business plan with numbers; Wall said a budget-projection spreadsheet and a fuller business plan will be provided to the full board before that meeting. Members also discussed pharmacy operations (the "pillbox" dispensary), prescription-transfer practices, and the need to improve community and staff communication about refill processes while the new pharmacy enrollment is maturing.
Whats next: Staff will prepare a business plan, budget projections and the requested HRSA attachments for the full board meeting so the board can consider whether to authorize the walk-in clinic pilot or include it on the upcoming seasonal plans.
